NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/30/2026
Back to search
Official data from USPTO
HYPHEN BIOMED
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HYPHEN BIOMED
ST13
US500000086339071Class
5
Filing
86339071
Registration
4952047
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
06/23/2026
Trademark type
Word
Nice classes
5
Filing date
07/16/2014
Registration date
05/03/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/30/2026
Last transaction
06/23/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/04/2002
First use in commerce
02/04/2002
Drawing code
4
Owner type
03
Owner location
Kobe, Hyogo, JP
Examiner
BLANDU, FLORENTINA
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
S. C. (pessoa física)
Representatives
Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic reagents and diagnostic preparations for medical or veterinary purposes; chemical reagents and chemical preparations for medicalveterinary or clinical diagnostic purposes; testing reagents and preparations for medicalveterinary or clinical diagnostic purposes; diagnostic preparations for use in clinical diagnostic and medical testingdiagnostic reagents and controls for immunochemistrycoagulationimmunohematologychemistrymicrobiologyhematologyimmunologyserology; reagents for blood coagulation analysis for medicalveterinary or clinical diagnostic purposes; diagnostic reagents for thrombosishemostasis and autoimmunity analysis for medical or veterinary purposes; test kits consisting primarily of diagnostic preparations for medical or veterinary use; buffer solutions for medicalveterinary or clinical diagnostic use; diluents for medicalveterinary or clinical diagnostic use; control materials for calibrating medical or veterinary apparatusstandard samples for use with checking the apparatus and calibrators; chemical reference materials for medicalveterinary or clinical diagnostic use; quality control standard solutions and quality control materials to be used for controls of medical or veterinary apparatus; calibration solutions for medicalveterinary or clinical diagnostic use; preparations of known concentration used for setting up standard curves for medicalveterinary or clinical diagnostic use
Publications
History of USPTO decisions and trademark events.
43 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/30/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/30/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/30/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
03/27/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/03/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/28/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/28/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/28/2022
E815
TEAS SECTION 8 & 15 RECEIVED
05/17/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/03/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
05/03/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/01/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/31/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/29/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/26/2016
EX2G
SOU EXTENSION 2 GRANTED
03/26/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/25/2016
IUAF
USE AMENDMENT FILED
02/24/2016
EXT2
SOU EXTENSION 2 FILED
02/24/2016
EEXT
SOU TEAS EXTENSION RECEIVED
02/24/2016
EISU
TEAS STATEMENT OF USE RECEIVED
02/24/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/22/2015
EX1G
SOU EXTENSION 1 GRANTED
08/20/2015
EXT1
SOU EXTENSION 1 FILED
08/20/2015
EEXT
SOU TEAS EXTENSION RECEIVED
08/20/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/24/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/30/2014
PUBO
PUBLISHED FOR OPPOSITION
12/30/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/10/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/22/2014
ALIE
ASSIGNED TO LIE
11/22/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/04/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
11/04/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/04/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
11/04/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/04/2014
DOCK
ASSIGNED TO EXAMINER
10/28/2014
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
08/06/2014
ALIE
ASSIGNED TO LIE
07/28/2014
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
07/22/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/22/2014
NWAP
NEW APPLICATION ENTERED
07/19/2014
Continuous trademark protection
Get notified about every new filing that threatens HYPHEN BIOMED or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.